Literature DB >> 1440471

High resolution computed tomography as a predictor of lung histology in systemic sclerosis.

A U Wells1, D M Hansell, B Corrin, N K Harrison, P Goldstraw, C M Black, R M du Bois.   

Abstract

BACKGROUND: The relative proportions of fibrosis and inflammation seen by open lung biopsy examination is a predictor of disease outcome in fibrosing alveolitis. This study was designed to assess the ability of high resolution computed tomography to predict the histological appearance of open lung biopsy specimens from patients with systemic sclerosis.
METHODS: Twenty abnormal biopsy specimens from 12 patients were assessed; abnormalities were categorised as fibrotic (fibrosis exceeding inflammation) or inflammatory (inflammation equal to or exceeding fibrosis). Computed tomography appearances were scored for the lobe from which the biopsy specimen was taken; scans were graded from parenchymal opacification alone through to a reticular pattern alone.
RESULTS: Two lobar appearances were identified on computed tomograms: amorphous parenchymal opacification equal in extent to reticulation (grade 3) and a predominantly reticular pattern (grade 4). There was a significant association between a fibrotic histological appearance and a grade 4 computed tomogram, and between an inflammatory histological appearance and a grade 3 computed tomogram. Computed tomography grade 4 was associated with a fibrotic histological appearance in 12 out of 13 lobes, and grade 3 with an inflammatory histological appearance in four out of seven lobes.
CONCLUSION: Computed tomography discriminated between biopsy specimens that were predominantly fibrotic and a smaller group with a larger amount of inflammation.

Entities:  

Mesh:

Year:  1992        PMID: 1440471      PMCID: PMC474812          DOI: 10.1136/thx.47.9.738

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  19 in total

1.  Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography.

Authors:  J R Mathieson; J R Mayo; C A Staples; N L Müller
Journal:  Radiology       Date:  1989-04       Impact factor: 11.105

2.  Disease activity in idiopathic pulmonary fibrosis: CT and pathologic correlation.

Authors:  N L Müller; C A Staples; R R Miller; S Vedal; W M Thurlbeck; D N Ostrow
Journal:  Radiology       Date:  1987-12       Impact factor: 11.105

3.  A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis.

Authors:  L C Watters; T E King; M I Schwarz; J A Waldron; R E Stanford; R M Cherniack
Journal:  Am Rev Respir Dis       Date:  1986-01

4.  Interstitial lung disease: the role of the radiologist.

Authors:  I H Kerr
Journal:  Clin Radiol       Date:  1984-01       Impact factor: 2.350

5.  Natural history and treated course of usual and desquamative interstitial pneumonia.

Authors:  C B Carrington; E A Gaensler; R E Coutu; M X FitzGerald; R G Gupta
Journal:  N Engl J Med       Date:  1978-04-13       Impact factor: 91.245

6.  Cryptogenic fibrosing alveolitis: assessment by graded trephine lung biopsy histology compared with clinical, radiographic, and physiological features.

Authors:  P H Wright; B E Heard; S J Steel; M Turner-Warwick
Journal:  Br J Dis Chest       Date:  1981-01

7.  Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival.

Authors:  M Turner-Warwick; B Burrows; A Johnson
Journal:  Thorax       Date:  1980-08       Impact factor: 9.139

8.  Cryptogenic fibrosing alveolitis: clinical features and their influence on survival.

Authors:  M Turner-Warwick; B Burrows; A Johnson
Journal:  Thorax       Date:  1980-03       Impact factor: 9.139

9.  Structural features of interstitial lung disease in systemic sclerosis.

Authors:  N K Harrison; A R Myers; B Corrin; G Soosay; A Dewar; C M Black; R M Du Bois; M Turner-Warwick
Journal:  Am Rev Respir Dis       Date:  1991-09

10.  Pulmonary involvement in systemic sclerosis: the detection of early changes by thin section CT scan, bronchoalveolar lavage and 99mTc-DTPA clearance.

Authors:  N K Harrison; A R Glanville; B Strickland; P L Haslam; B Corrin; B J Addis; R Lawrence; A B Millar; C M Black; M Turner-Warwick
Journal:  Respir Med       Date:  1989-09       Impact factor: 3.415

View more
  28 in total

Review 1.  Review of cryptogenic fibrosing alveolitis, including current treatment guidelines.

Authors:  S C Bourke; H Clague
Journal:  Postgrad Med J       Date:  2000-10       Impact factor: 2.401

2.  T-889C IL-1alpha promoter polymorphism influences the response to oral cyclophosphamide in scleroderma patients with alveolitis.

Authors:  Lorenzo Beretta; Francesca Cappiello; Morena Barili; Francesca Bertolotti; Raffaella Scorza
Journal:  Clin Rheumatol       Date:  2006-04-25       Impact factor: 2.980

3.  Lung findings on thoracic high-resolution computed tomography in patients with ankylosing spondylitis. Correlations with disease duration, clinical findings and pulmonary function testing.

Authors:  Abdellah El Maghraoui; Souad Chaouir; Ahmed Abid; Ahmed Bezza; Fatima Tabache; Lahsen Achemlal; Ali Abouzahir; Driss Ghafir; Victor Ohayon; Moulay Idriss Archane
Journal:  Clin Rheumatol       Date:  2004-02-24       Impact factor: 2.980

4.  Reliability, validity and responsiveness to change of the Saint George's Respiratory Questionnaire in early diffuse cutaneous systemic sclerosis.

Authors:  Beth Wallace; Suzanne Kafaja; Daniel E Furst; Veronica J Berrocal; Peter A Merkel; James R Seibold; Maureen D Mayes; Dinesh Khanna
Journal:  Rheumatology (Oxford)       Date:  2015-02-09       Impact factor: 7.580

5.  The impact of slice-reduced computed tomography on histogram-based densitometry assessment of lung fibrosis in patients with systemic sclerosis.

Authors:  Thi Dan Linh Nguyen-Kim; Britta Maurer; Yossra A Suliman; Fabian Morsbach; Oliver Distler; Thomas Frauenfelder
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

6.  Association between 'interleukin' 10 gene (IL10) polymorphisms and systemic sclerosis with interstitial lung involvement.

Authors:  O Ates; B Müsellim; G Ongen; A Topal-Sarikaya
Journal:  Rheumatol Int       Date:  2008-05-21       Impact factor: 2.631

7.  Clinical, laboratory and radiological findings in pulmonary fibrosis with and without connective tissue disease.

Authors:  E Renzoni; P Rottoli; G Coviello; M G Perari; M Galeazzi; M Vagliasindi
Journal:  Clin Rheumatol       Date:  1997-11       Impact factor: 2.980

Review 8.  Scleroderma lung disease.

Authors:  Joshua J Solomon; Amy L Olson; Aryeh Fischer; Todd Bull; Kevin K Brown; Ganesh Raghu
Journal:  Eur Respir Rev       Date:  2013-03-01

9.  Systemic sclerosis: comparison of efficacy of oral cyclophosphamide and azathioprine on skin score and pulmonary involvement-a retrospective study.

Authors:  Hadi Poormoghim; Nader Rezaei; Zeinab Sheidaie; Ali Reza Almasi; Maziar Moradi-Lakeh; Simin Almasi; Elham Andalib
Journal:  Rheumatol Int       Date:  2014-05-07       Impact factor: 2.631

10.  Correlation between HRCT findings, pulmonary function tests and bronchoalveolar lavage cytology in interstitial lung disease associated with rheumatoid arthritis.

Authors:  J Biederer; A Schnabel; C Muhle; W L Gross; M Heller; M Reuter
Journal:  Eur Radiol       Date:  2003-10-14       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.